Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk.

[1]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[2]  F. Kronenberg,et al.  Lipoprotein(a): resurrected by genetics , 2013, Journal of internal medicine.

[3]  C. Naugler,et al.  Fasting time and lipid levels in a community-based population: a cross-sectional study. , 2012, Archives of internal medicine.

[4]  Anne Tybjærg-Hansen,et al.  Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Steiner,et al.  Fasting Might Not Be Necessary Before Lipid Screening: A Nationally Representative Cross-sectional Study , 2011, Pediatrics.

[6]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[7]  B. Nordestgaard,et al.  Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis , 2011 .

[8]  T. Hashimoto,et al.  Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques. , 2011, Atherosclerosis.

[9]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[10]  P. R. Kamstrup.  Lipoprotein(a) and ischemic heart disease--a causal association? A review. , 2010, Atherosclerosis.

[11]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[12]  Stephen Kaptoge,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[13]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[14]  B. Nordestgaard,et al.  Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction , 2008, Circulation.

[15]  Børge G Nordestgaard,et al.  Genetically elevated C-reactive protein and ischemic vascular disease. , 2008, The New England journal of medicine.

[16]  M. Koschinsky,et al.  Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Samia Mora,et al.  Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events , 2008, Circulation.

[18]  H. Cai,et al.  Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[19]  R. Tracy,et al.  High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  B. Nordestgaard,et al.  Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study , 2008 .

[21]  P. Ridker,et al.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.

[22]  B. Nordestgaard,et al.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. , 2007, JAMA.

[23]  B. Polat,et al.  Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation , 2005, Rheumatology International.

[24]  Arjun Deb,et al.  Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis , 2004, Clinical cardiology.

[25]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[26]  G. Utermann,et al.  The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration , 1992, Human Genetics.

[27]  E. Boerwinkle,et al.  Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups , 1991, Human Genetics.

[28]  R. Simari,et al.  Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. , 2001, Blood.

[29]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[30]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[31]  F. Kronenberg,et al.  Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). , 1998, Kidney international.

[32]  R. Sacco,et al.  Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. , 1998, Atherosclerosis.

[33]  W. Min,et al.  Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease. , 1997, Clinical chemistry.

[34]  H. Hobbs,et al.  Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. , 1996, Clinical chemistry.

[35]  M. Seishima,et al.  Lp(a): an acute-phase reactant? , 1994, Chemistry and physics of lipids.

[36]  E. Boerwinkle,et al.  Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  R. Mensink,et al.  Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. , 1992, Journal of lipid research.

[38]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[39]  M. Noakes,et al.  Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. , 1992, Journal of lipid research.

[40]  G. Dahlén,et al.  Lipoprotein(a) and acute-phase proteins in acute myocardial infarction. , 1992, Scandinavian journal of clinical and laboratory investigation.

[41]  D. Sullivan,et al.  Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states. , 1991, Atherosclerosis.

[42]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[43]  M. Seishima,et al.  Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.

[44]  J. Ordovás,et al.  Postprandial plasma lipoprotein changes in human subjects of different ages. , 1988, Journal of lipid research.

[45]  W. C. Breckenridge,et al.  Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[46]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.